Review of issues related to methods, criteria and indicators for widening actions by Peck, Frank
Peck, Frank (2018) Review of issues related to methods, criteria and indicators for 
widening actions. European Commission, Luxembourg. 
Downloaded from: http://insight.cumbria.ac.uk/id/eprint/4155/
Usage of any items from the University of  Cumbria’s  institutional repository ‘Insight’  must conform to the  
following fair usage guidelines.
Any item and its associated metadata held in the University of Cumbria’s institutional  repository Insight (unless 
stated otherwise on the metadata record) may be copied, displayed or performed, and stored in line with the JISC 
fair dealing guidelines (available here) for educational and not-for-profit activities
provided that
• the authors, title and full bibliographic details of the item are cited clearly when any part
of the work is referred to verbally or in the written form 
• a hyperlink/URL to the original Insight record of that item is included in any citations of the work
• the content is not changed in any way
• all files required for usage of the item are kept together with the main item file.
You may not
• sell any part of an item
• refer to any part of an item without citation
• amend any item or contextualise it in a way that will impugn the creator’s reputation
• remove or alter the copyright statement on an item.
The full policy can be found here. 
Alternatively contact the University of Cumbria Repository Editor by emailing insight@cumbria.ac.uk.
 Professor Frank Peck, University of Cumbria, UK 
June – 2018 
 
 
 
 
 
 
 
Review of Issues Related to 
Methods, Criteria and Indicators 
for Widening Actions
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Review of Issues Related to Methods, Criteria and Indicators for Widening Actions  
European Commission 
Directorate-General for Research and Innovation 
Directorate B 
Unit B5 — Spreading Excellence and Widening Participation 
Contact  Dionysia Lagiou 
E-mail  Dionysia.lagiou@ec.europa.eu 
 RTD-PUBLICATIONS@ec.europa.eu 
European Commission 
B-1049 Brussels 
Manuscript completed in June 2018. 
This document has been prepared for the European Commission however it reflects the views only of the authors, and the 
Commission cannot be held responsible for any use which may be made of the information contained therein. 
More information on the European Union is available on the internet (http://europa.eu). 
Luxembourg: Publications Office of the European Union, 2018 
 PDF  ISBN 978-92-79-87951-7  DOI 10.2777/636491 KI-01-18-676-EN-N 
 
© European Union, 2018. 
 
Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by 
Decision 2011/833/EU (OJ L 330, 14.12.2011, p. 39). 
For any use or reproduction of photos or other material that is not under the EU copyright, permission must be sought directly 
from the copyright holders. 
 
  
EUROPEAN COMMISSION 
 
 
 
 
 
 
Review of Issues Related to Methods, 
Criteria and Indicators for Widening Actions 
 
 
 
 
 
Written by 
Professor Frank Peck, University of Cumbria, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directorate-General for Research and Innovation 
2018 Spreading Excellence and Widening Participation  
 2 
 
Table of Contents 
EXECUTIVE SUMMARY ........................................................................................ 3 
REVIEW OF ISSUES RELATED TO METHODS, CRITERIA AND INDICATORS FOR 
WIDENING ACTIONS .......................................................................................... 5 
1 Purpose of Horizon 2020: Measuring Outcomes .................................................. 5 
2 European Research Area (ERA): Headline Research Indicators .............................. 6 
3 Innovation Divides: Indicators .......................................................................... 8 
4 Participation in H2020 ....................................................................................12 
5 H2020, Regions and the Scale Issue in Measurement .........................................14 
6 Aligning FP Research and Innovation to ESIF .....................................................15 
7 Spreading Excellence and Widening Participation ...............................................16 
8 Implications for Indicators for Future Widening Action ........................................19 
9 Indicators for Future Widening Actions .............................................................21 
9.1 Socio-economic status – GDP per capita (PPS Index) ...................................21 
9.2 Productivity – GDP per worker and per hour ...............................................23 
9.3 Economic Structure – Employment in knowledge intensive activity ................25 
9.4 Levels of Innovation in Business Enterprises ...............................................27 
9.5 R&D Expenditure .....................................................................................30 
9.6 Publication .............................................................................................32 
9.7 Research Excellence and Institutional Status of HEIs ...................................36 
9.8 Patenting ...............................................................................................38 
9.9 JRC Research Excellence Index .................................................................40 
9.10 European Innovation Scoreboard Index ......................................................42 
10 Conclusion and Recommendations ...................................................................44 
10.1 Economic Indicators ................................................................................44 
10.2 Research & Innovation single indicators .....................................................44 
10.4 Summary ...............................................................................................45 
10.5 Using Indicators as Filters for Identifying Future Widening Countries .............49 
11 References ....................................................................................................52 
 
 
 
 
 
 3 
EXECUTIVE SUMMARY 
 
1. This report considers issues related to the criteria and indicators that might be 
used to define targets for future “Widening Actions” designed to address 
inequality in research and innovation performance across EU Member States.  
Under Horizon 2020, this has been the focus of the “Spreading Excellence and 
Widening Participation” Work Programme.  
2. The selection of indicators needs to be informed by the characteristic of 
inequality in research and innovation.  In this regard, it is important to 
recognize that the overall purpose of the EU investment in science and 
innovation is to drive economic growth.  This raises questions regarding the 
use of economic indicators alongside measures of research and innovation 
performance in future “widening” targeting.   
3. Research and innovation systems operate at a variety of spatial scales, 
including regional as well as national and supra-national.  However, it is 
recognized that national systems remain critical for innovative performance.  
The European Research Area (ERA) objective is to create a genuine “single 
market” for knowledge, research and innovation.  ERA objectives have been 
strongly focused on integration of national research and innovation systems.   
4. Recent research indicates the existence of various “innovation divides” 
between Member States.  A difference in performance is still discernable 
between western and eastern Europe.  There is also an emerging divide within 
eastern Europe as some Members States have outperformed others.  Recent 
studies also show an emerging north-south divide in research and innovation 
performance with below average performances in Portugal, Spain and Greece.   
5. There are variations between Member States in levels of participation in 
H2020.  These patterns of participation do not precisely match the research 
and innovation divides.  There are some very high performing Member States 
whose participation in H2020 is quite modest.  Some EU13 Member States 
with below average performances in research also display low participation 
rates in H2020.   
6. Research demonstrates that indicators of research and innovation are scale-
dependent.  Some larger countries may display only modest performance due 
to averaging between very high performing metropolitan regions and weaker 
peripheries.  On the other hand, indicators can be misleading for smaller 
countries due to boundary effects and variability associated with small scale.   
7. There may be advantages in closer alignment between research and 
innovation interventions and the European and Structural Investment Fund 
(ESIF). This suggests that indicators that are relevant to both these policy 
fields, and also available at national as well as regional scales, could be 
advantageous.   
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8. In the context described above, this document examines the merits of a range 
of possible indicators of future performance that includes socio-economic 
indicators alongside measures of research and innovation performance.  The 
assessment covers the following indicators:  
9. Socio-economic indicators  Socio-economic status – GPD per capita (PPS Index)  Productivity – GDP per worker / GDP per hour  Economic Structure – Percent of employment in knowledge intensive 
activity  Business Innovation - % Enterprises classed as “innovation active”  
10.  Research and innovation single indicators  Expenditure – Gross R&D Expenditure as a percent of GDP  Publication - highly-cited scientific publications per million population   Publication – % total scientific publications that is highly-cited  Research Excellence and Institutional Capability – Top 500 Universities  Patents – total number of PCT patent applications per million population 
11. Research and innovation composite indicators  Research composite indicator - JRC Research Excellence Indicator  Innovation composite indicator – European Innovation Scoreboard Index 
12. The assessment indicates that there are advantages and disadvantages to all 
potential indicators and that no single indicator adequately captures all 
aspects of the research and innovation process.  Existing composite indicators 
could be adopted, but there are disadvantages in terms of complexity, 
timeliness and the ease with which these indicators can be reproduced.   
13.  An alternative approach to combining indicators is proposed based on 
“filtering” Member States using their ranking on three selected variables:   Economic status – GDP per head  Research performance - % of scientific publications in the top 10% 
citations  Innovation performance – Number of PCT Patent applications per million 
population 
14.  Of the three indicators short-listed, it is noted that “% of scientific 
publications in the top 10% citations” is the most direct anticipated outcome 
from any investment in research activity.   
15.  On this basis, the following recommendations are made:  
a) That the Commission considers further the merits of a “filtering” approach 
based on the three shortlisted variables;  
b) That further checks are made on the three shortlisted variables to test 
their reliability and consistency from year to year;  
c) That a decision to select just one of the short-listed variable for targeting 
purposes should be accompanied by further detailed assessment of its 
sensitivity over time and between Member States.   
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REVIEW OF ISSUES RELATED TO METHODS, CRITERIA AND 
INDICATORS FOR WIDENING ACTIONS  
This report contributes to discussions within the European Commission 
Directorate-General for Research & Innovation concerning the selection of 
indicators for future Widening Actions within EU Framework Programme 9.  
“Widening Actions” refers to the “Spreading Excellence and Widening 
Participation” objective that is currently being delivered under Horizon 2020.  The 
purpose of “Widening” is to address uneven performance between Member States 
in research and innovation.   
The report develops arguments that may be important in seeking to justify the 
appropriateness of different indicators and approaches to using data as a basis 
for selecting target countries.  The structure of this report is predicated on the 
principle that the selection of indicators and use of data needs to be guided by 
understanding of the policy objectives and the rationale for intervention in 
research and innovation processes.  Before addressing the specific issues 
surrounding data and indicators, this report reviews the context of “widening” by 
summarizing the following:   The overall purpose of H2020  Objectives of the European Research Area (ERA)  The “innovation divides” in Europe  Variation in participation in H2020  Regions and the “scale” issue in Research & innovation  FP Research & Innovation and European Structural and Investment Funds  Objectives of Spreading Excellence and Widening Participation (SEWP) 
The discussions in sections 2 to 8 are based on existing policy documents and 
recent publishes evaluations and analyses of data.  This is not intended as a 
comprehensive review of these policies but a discussion focused on the 
relationships between overall purpose and targeting using indicators.  Section 9 
then attempts to summarise these issues and provide a framework for discussion 
of indicators for future Widening Actions.   
On the basis of the analysis from literature, section 10 presents eight indicators 
that could form the basis of a methodology to define targets for future Widening.  
These include measures of socio-economic outcomes as well as those that relate 
to outputs from research & innovation activity.  Consideration is given to single 
indicators as well as composite indicators.   
1 Purpose of Horizon 2020: Measuring Outcomes 
In approaching issues concerning targeting of resources in any future Widening 
programme, it is important to consider this in the context of the overall objectives 
of Research and Innovation in the European Union.  If we assume continuity with 
Horizon 2020, the objectives will continue an emphasis on the three pillars that 
informed the current programme.  There is likely, therefore, to be continued 
focus on promoting and supporting excellence in scientific research, generating 
economic impact through innovation and industrial leadership as well as 
addressing societal challenges (H2020 interim evaluation, EC 2017a).   
It is also significant to note that while the objectives of H2020 are specified in 
relation to excellence in scientific research and innovation, the EU Framework 
Programme represent a response to the need to create jobs and growth in the 
EU.  This is restated explicitly in the Interim Evaluation of Horizon 2020 published 
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in 2017.  “Horizon 2020 was designed to drive economic growth and create jobs 
by coupling research and innovation (R&I) with an emphasis on excellent science, 
industrial leadership and tackling societal challenges.  The general objective is to 
contribute to the EU’s overarching jobs and growth strategy by; helping to build a 
society and an economy based on knowledge and innovation across the Union”  
(EC 2017a, p. 10).   
 The vital link between scientific excellence and economic growth is also made 
explicitly in a recent report on Science, Research and Innovation Performance of 
the EU that addresses the significance of open innovation and open science (EC 
2016).  The executive summary starts as follows:  “A continuing productivity 
challenge is hindering the European Union from re-taking the path towards 
sustainable economic growth and the creation of high quality jobs” (p.8).  The 
clear inference to draw from this is that the commitment of the EU to invest in its 
science base is not simply for its own sake but because of the belief that a 
stronger science base will address the competitiveness or “productivity gap” 
between the EU and its major global competitors, in particular the US and Japan.   
“Addressing the GDP gap between the EU and the US and thereby 
restoring the EU’s long term competitiveness will therefore ultimately 
require raining labour productivity.  This depends in turn on increasing 
multifactor productivity which relates to innovation and investments such 
as R&D, ICT and skills development” (EC 2016, p. 8).   
These policy statements and associated arguments about the causal links 
between investment in research and innovation and economic growth suggest 
that some consideration should be given to the possibility of including measures 
of the overall economy in targeting Widening Actions.  This point is considered 
further in sections 9 and 10.   
2 European Research Area (ERA): Headline Research Indicators  
While implementation of Horizon 2020 has taken into consideration the spatial or 
territorial context, its priorities have primarily been guided by the need to 
strengthen the EU’s science-base and improve innovation in the EU as a whole.  
Spatial considerations have therefore focused on the completion and development 
of the European Research Area and specifically through the implementation of the 
“Spreading Excellence & Widening Participation” objective.   
Aligned to the EU Framework Programme, the general purpose of ERA has been 
to work towards the creation of a genuine “single market” for knowledge, 
research and innovation (EC 2017b).  Its objectives have been defined as follows:   To create more effective national research systems  To promote optimal transnational co-operation and competition  To create an open labour market for researchers  To promote gender equality and gender mainstreaming in research  To promote optimal circulation, access to and transfer of scientific knowledge 
including “knowledge circulation” and “Open Access”  To promote international cooperation in science and innovation 
The “Spreading Excellence and Widening Participation” work programme under 
H2020 has therefore been a significant contributor to attempts to deliver ERA 
objectives.  It is particularly pertinent in the debate concerning indicators for 
future widening that the ERA objectives are strongly focused on the integration of 
national research and innovation systems.   
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As a policy objective for ERA, the emphasis on national systems and national 
indicators can be justified in various ways.  National research and innovation 
systems have a very powerful influence on the knowledge base through 
government funding for research, industrial innovation and business support.  
Promoting transnational cooperation in research and innovation through the 
mechanism of H2020 is therefore entirely plausible as a means of improving the 
performance of the EU research base. This is likely to lead to greater knowledge 
exchange and wider access to new scientific ideas.  
This approach to investment in research and innovation is consistent with a broad 
area of academic literature that considers the ways in which innovation occurs 
within economies.  One of the leading authors in this field, Bengt-Ake Lundvall 
(2007), has reviewed the concept of innovation systems demonstrating that the 
concept originated in the 1980s as a phenomenon applied to the national scale.  
An “innovation system” has been variously defined as a set of public and private 
institutions that interact in the development and diffusion of economically useful 
new knowledge.   
The significance of National Innovation Systems is that many of institutions that 
form innovation systems, including governments, operate at a national scale. It 
is, of course, evident that there will be variations between countries in terms of 
the role of sub-national territories that generate regional innovation systems 
(Asheim et al, 2016).  Also, national innovation systems vary in their degree of 
openness to global influence particularly since the concept of open innovation has 
been widely promoted. Lundvall accepts that innovation systems can operate at a 
variety of spatial scales, but that these are not alternatives to the analysis of 
national systems.  Furthermore, institutions that operate at the national scale still 
exercises a major influence over the process of research and innovation and that 
“especially in the current period of globalisation, the focus on the national level is 
important and legitimate (Lundvall 2007, p. 100).   
Given these policy directions, it is clear, that the relative performance of national 
research and innovation systems and the levels of interaction between them are 
key phenomena for ERA and hence for the Spreading Excellence and Widening 
Participation agenda.  In this context, ERA has invested considerably in distilling 
key variables for comparing the performance of Member States and Associate 
Countries.  The ERA Monitoring Handbook (EC 2017b) assessing the relative 
merits of different indicators and produces a matrix of headline indicators aligned 
to each of the Strategic Priorities of ERA.  Under Priority 1 – More effective 
national research systems – the handbook identifies three headline indicators as 
shown in Table 1. 
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Table 1:  ERA Headline Indicators for Priority 1: More Effective National 
Research Systems 
 Input Indicator Output 
Indicator 
Outcome/Impact 
Indicator 
Definition 
Government Budget 
Allocation for R&D 
(GBARD) as % of 
Gross Domestic 
Product (GDP) 
Adjusted Research 
Excellence Index 
(REI) 
European Innovation 
Scoreboard Summary 
Innovation Index (SII) 
Source Eurostat 
Joint Research 
Centre (JRC) 
European Innovation 
Scoreboard (EIS) 
Source: EC (2017) ERA Monitoring Handbook 2016 Report by Science-Metrix, Page 5 
The indicators identified as key for measuring progress towards targets for ERA 
focus understandably on different aspects of research and innovation (inputs, 
activities, outputs, impacts).  It is significant to note, however, that measures of 
overall economic performance are not included.  This is perhaps surprising given 
the statements noted above about the overall purpose of the Framework 
Programme and the logic of investment in “open science and open innovation”. 
This point will be discussed further in relation to choice of indicators for SEWP 
that presently do not include measures of national economic performance.   
3 Innovation Divides: Indicators 
In the context of the relative performance of national research and innovation 
systems, there is considerable policy debate concerning what are referred to as 
“innovation divides” at the national scale across the EU.  The existence of 
“innovation divides” is not new.  Indeed, the whole concept of ERA from its 
inception was couched in terms of an innovation gap between the EU and its 
major global competitors in the United States and Japan.  Europe, it was argued, 
needs to invest more in the production and dissemination of knowledge in order 
to maintain economic growth, competitiveness and employment (EC 2000, p.5).   
It was argued that closing this global divide requires investment in the integration 
of European research effort in order to address the fact that “Europe’s scientific 
and technological fabric lacks cohesion” p. 18.  There needs to be a 
“territorialisation of research policies……. a better understanding and 
strengthening is needed of the role that the regions can play, in addition to the 
Member States of the Union”.   
However, the immediate focus of addressing cohesion since 2000 has been to 
integrate the scientific communities of Western and Eastern Europe.  It was 
recognised that there was a need to “improve the research capacities of the 
Countries applying for accession and integrating their researchers in the 
European scientific community”  (EC 2000, p. 18).   
Studies applied to the period of FP7, 2006 to 2013, have identified some 
convergence in research and innovation performance but significant divides 
remain.  There is no simple empirical description of this divide.  Using indicators 
from the Innovation Union Scoreboard (IUS), Veugelers et al (2016) have shown 
that, at least in terms of IUS indicators, there is no simple east-west division.  
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Some countries that have joined the EU since 2000 outperform others 
considerably, in particular Estonia and Slovenia.  There is also a strong north-
south divide particularly with regard to finance as an enabler.  Since the 
economic crisis, the divide between countries in terms of public spending on 
research and development relative to GDP has increased.  “Innovation–leading 
countries have forged ahead but the followers have not been able to keep up, 
leaving a wider gap in public R&I spending now than before the crisis” Veugelers 
et al (2016 p. 11).   
If the pattern of innovation performance defies simply description, the causes of 
these apparent variations between Member States and associate countries 
introduce even greater complexity.  This can be seen by disaggregating some of 
the components of innovation performance.  One key aspect concerns national 
variation in the level of “research intensity” (R&D Expenditure as a proportion of 
GDP) that is one of the five key headline targets of the Europe 2020 Strategy.   
Quite clearly, variation in the level of resource input is likely to one key 
explanation for any variation in the quality and quantity of research output and 
innovation performance.  In a recent review of science, research and innovation 
performance of the EU (EC 2016), R&D Intensity for 2014 is shown to vary 
considerably between member states.  Table 2 reinforces the point made by 
Veugelers et al (2016) that while there are some systematic differences between 
east and west, this generalization has an increasing number of notable 
exceptions.  Slovenia, the Czech Republic, Estonia and Hungary display high 
growth in R&D Intensity 2007-2014 and out-perform many EU-15 Countries in 
2014.  Several EU-15 countries are ranked below these high-performing EU-13 
member states including several that have experienced recent decline in this 
indicator (Portugal -1.9%; Spain -0.4).   
Data on R&D outputs are also analysed in this document, including levels of 
scientific publication.  Table 3 shows countries ranked according to a measure of 
the quality of research outputs based on citation (percent of authors in each 
country that have been associated with at least one publication in the top 10% 
most highly cited in the world).  There is no single or simple measure of research 
quality, but the level of citation by other authors is one indicator that has been 
used, though we should acknowledge that citation is a surrogate of quality and 
there may be reasons for variation in citation that have nothing to do with 
quality.   
It is, however, likely that high quality research will also be widely cited.  The rank 
order mirrors the conclusions drawn above concerning “divides” across the EU.  
There is a broad divide between east and west but also elements of a north-south 
divide with below average performance in Portugal, Spain and Greece.  There are 
also contrasts within central and eastern Europe with stronger performances in 
Estonia, Slovenia, Hungary and the Czech Republic compared to others.   
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Table 2:  National variations in R&D Intensity in 2014 (Expenditure on 
R&D as a percentage of GDP) 
Member State R&D Intensity 2014 
(provisional) 
R&D Intensity 
compound annual growth 
(%) 
2007-2014 
Finland 3.17 -0.8 
Sweden 3.16 -0.4 
Denmark 3.08 3 
Austria 2.99 3 
Germany 2.84 2.2 
Belgium 2.46 4.2 
Slovenia 2.39 4.5 
France 2.26 2.1 
Czech Republic 2 6.3 
Netherlands 1.97 1 
United Kingdom 1.72 0.3 
Ireland 1.55 3.3 
Estonia 1.46 4.6 
Hungary 1.38 5.3 
Italy 1.29 1.8 
Portugal 1.29 -1.9 
Luxembourg 1.24 -3.6 
Spain 1.2 -0.4 
Lithuania 1.02 3.5 
Poland 0.94 7.5 
Slovakia 0.89 10.2 
Malta 0.85 6.4 
Greece 0.83 3.8 
Bulgaria 0.8 9 
Croatia 0.79 -0.1 
Latvia 0.68 2.9 
Cyprus 0.47 2.2 
Romania 0.38 -6.3 
EU 2.03 1.9 
Source:  Data abstracted from figure 1-2-11 in EC (2016) Science, Research and Innovation 
Performance of the EU: Open Innovation, Open Science, Open to the World agenda P 3 
 
  11 
Table 3:  Authors in a country with at least one publication in top 10% 
most highly cited in the world (Citation window up to 2013) 
 Authors with pub 
10% 
% Authors with top 
10% 
Netherlands 59,465 35.0 
Switzerland 43,481 34.1 
Denmark 21,891 33.9 
Sweden 36,507 31.8 
Finland 18,204 31.6 
Belgium 28,378 30.8 
United Kingdom 181,507 30.3 
Iceland 4,088 28.7 
France 123,774 28.6 
Germany 171,508 28.6 
Italy 96,604 28.5 
Norway 14,060 28.1 
EU 822,456 27.4 
Austria 18,124 27.1 
Ireland 9,157 25.4 
Portugal 10,241 22.2 
Luxembourg 398 21.3 
Spain 69,639 21.1 
Estonia 1,409 21.0 
Greece 14,505 19.8 
Cyprus 529 19.3 
Slovenia 2,762 18.1 
Hungary 6,739 16.5 
Czech 8,970 15.8 
Poland 14,668 12.3 
Romania 3,722 11.6 
Lithuania 1,042 11.5 
Bulgaria 1,702 11.0 
Slovakia 2,177 10.4 
Malta 101 10.3 
Latvia 337 10.2 
Croatia 2,379 9.6 
Serbia 1,275 9.1 
Source:  Analysis of data from SCOPUS database reported in EU (2016) Science, Research and 
Innovation Performance of the EU.  Data abstracted from Fig 11-3-8. P. 169; N.B. Analysis relates to 
publications in the period 2000-2010 and citation window through to 2013.   
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4 Participation in H2020 
The existence of complex innovation and research divides in Europe has been 
noted in section 4.  A recent report produced by the European Technology 
Assessment Group (ETAG, 2017) has also investigated variation in patterns of 
participation in Horizon 2020 (Science and Technology Options Assessment 
(STOA-Project, 2017).  This data also reveals variation across Member States.  
Before presenting these patterns, it should be noted that data on participation in 
H2020 is complex and considerable effort is required to “clean” information into a 
useable form.  H2020 projects are, for most part, complex consortia across 
countries and roles and responsibilities vary considerably between individuals 
involved.  Also, Member States vary in size considerably, and data therefore 
needs to be standardized using suitable denominators.  It should be noted that 
the patterns displayed are highly sensitive to the choice of denominator (e.g. 
population, GDP or number of scientists in each Member State).   
Data in Table 4 is taken from the STOA Report (ETAG, 2017).  This shows the 
number of participations for each type of funding scheme for Member States in 
H2020 per thousand FTE researchers.  It should be noted, therefore, that 
countries with comparatively small research communities could score very well on 
this indicator with relatively few successful participations.  As in the case of 
innovation divides, it is evident that E-13 Member States are more commonly in 
the lower half of rankings.  However, this is not always the case and significant 
exceptions remain.  Rates of participation in CP/IA/RIA, for instance vary 
considerably within the EU-15 with some very low rates of participation in 
countries that have very good R&I performance.   
The STOA report repeats a statement that has commonly been asserted that “no 
single indicator can adequately provide a complete picture of FP participation.  
EU-13 underperformance is a complex problem” (ETAG, 2017, p.19). In a 
commentary on low participation in FP7, the same point was made in 2011 
(Council of the European Union 2011) that “no single indicator can provide a 
complete picture of participation under FP8 or for that matter any other research 
programme”.  (p.3).    
Most of the time, EU13 can be found at the lower end of participating rankings.  
Yet some EU-13 Member States are developing quickly and have excellent 
research centre.  There is, in fact, considerable heterogeneity within the EU-13 
group and also within the EU-15.   These variations in H2020 participation, 
however, do not precisely match the “research and innovation divides” noted in 
sections above.  It is possible therefore to observe very high performing Member 
States whose participation in H2020 appears fairly modest (e.g. Denmark, 
Sweden).   
The report seeks to offer an explanation for these variations in participation 
specifically within the EU-13.  Statistical analysis provides some support for the 
following explanatory factors:   Lack of experienced coordinators in some EU-13 Member States  Weak collaborative networks with other centres of research  Weak National R&I Systems with low capacity to support bids  Perception of high administrative burden and low success rate 
It is concluded that uneven participation is perhaps unavoidable simply because 
of the primacy given to research excellence in assessing proposals and the 
competitive process.  However, the argument in support of special measures to 
spread excellence and widen participation remains compelling.   
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“The concentration of resources in a strong, excellent core whose competition 
position is reinforced through continued participation is problematic for 
organisations and countries that are currently excluded” (p. 29).   
Table 4:  Number of participations per type for selected funding schemes 
from the EU-15 and EU-13 in H2020 per thousand fte researchers 
 CP/IA/RIA CSAs 
EU15 10.7 2.9 
Austria 14.2 4.6 
Belgium 16.9 7.8 
Germany 8.1 1.8 
Denmark 9.4 2.7 
Greece 21.6 5.8 
Spain 17.5 4.5 
Finland 11.4 3.3 
France 6.6 1.9 
Ireland 15.2 4.3 
Italy 16.5 4.8 
Luxembourg 24.7 12.7 
Netherlands 16.6 4.2 
Portugal 11.4 4.8 
Sweden 8.7 2.0 
UK 8.0 1.8 
   
EU13 6.4 4.8 
Bulgaria 5.5 7.9 
Cyprus 98.4 53.8 
Czech Republic 5.7 2.5 
Estonia 18.1 15.0 
Croatia 8.8 13.6 
Hungary 6.4 3.7 
Lithuania 5.7 5.3 
Latvia 10.1 13.3 
Malta 29.9 36.2 
Poland 3.2 2.2 
Romania 9.1 8.0 
Slovenia 20.8 10.7 
Slovakia 4.9 4.7 
Source:  STOA (2017) abstracted from table on p. 40;  IA -  Innovation Actions; RIA - Research and 
Innovation Actions; CSA – Coordination and Support Actions.  
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5 H2020, Regions and the Scale Issue in Measurement 
The objectives of ERA and SEWP Programmes are specifically directed towards 
the national scale.  There is little doubt that national research and innovation 
systems are important in determining the capacity and capability to engage in 
high quality research and innovation.  However, some of the socio-economic 
processes that influence research and innovation operate at other scales, 
including the regional. The STOA Report recognizes this in its discussions of 
variations in participation.   
It is noted that participation is not just subject to national variation but there are 
also significant regional variations within Member States.  The discussion 
that follows this identifies some of the key regional processes that influence 
research and innovation including prominently institutional capacity, human 
capital and access to specialist equipment and facilities.  Agglomeration 
factors are also significant in that learning accumulates over long periods of time 
and major centres of population act as reservoirs of “accumulated practical 
experience and skills”. (ETAG 2017, p. 23)  
“Another way of looking at participation is the measure of regional 
concentration. Regional and institutional disparities of participants, i.e. 
spatial and institutional concentration of participants in more developed 
regions and in research stronger and larger institutions, concentration of 
research resources in terms of human capital, equipment, large 
infrastructure as well as in project management capacities through 
accumulation of practical experience and skills can be the most critical 
factors for success in EU projects”. (ETAG 2017 p.23) 
It is relevant to note that an analysis of low participation in FP7 circulated by the 
Council of the European Union in 2011 refers to regional concentration as an 
issue for the future Framework Programme.  It was noted that in many countries 
“there appears to be a significant concentration of research activity in a few 
major centres”  (Council of the European Union, 2011, p.3).  It is also the case 
that many high performing research institutions are concentrated within larger 
metropolitan areas and capital city-regions across Member States.  There is, of 
course, a considerable academic literature on the role of regions in innovation 
processes that focuses in particular on the significance of institutional capacity 
and “tacit knowledge” for economic development.  
The regional scale effects have several important implications for the present 
study that focuses on national variation in research and innovation. Firstly, some 
larger countries may in fact represent averages of very high performance 
research-intensive regions alongside much weaker peripheral regions.  In these 
circumstances, national indicators will display only moderate or even poor 
performances.  In other instances, some Member States occupy limited territories 
that are smaller than many regions in larger Member States.  Indicators of 
research and innovation activity for small states are likely to experience much 
greater volatility over time and appear as outliers in statistical analyses.   
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6 Aligning FP Research and Innovation to ESIF  
The Joint Institute for Innovation Policy (JIIP) has recently reported on the 
synergies between the Framework Programmes for Research and Innovation and 
European Structural and Investment Funds (EC 2017c).  The document notes that 
most (86.8%) H2020 work programmes refer to European Structural and 
Investment Funds (ESIF) in their specifications although the reference is 
sometimes in passing or in footnotes.  Most calls for proposals ask applicants to 
“consider” the link with ESIF but specific guidance on how to achieve this is often 
absent.   
The results of a survey of H2020 National Contact Points (NCPs) reveal that there 
is limited exchange of information between these programmes but a recognition 
that there are benefits in achieving this for both.  It is relevant to the context of 
SEWP, however, that proposals from EU-13 Member States are more active in 
this regard than the EU-15.  The report highlights the need to harmonise the two 
programmes in terms of accounting practices, timing and methods of reporting.   
The JIIP report suggests that strategic alignment between place-based 
innovation investments through ESIF and world-class research and 
innovation initiatives via the Framework Programme could be highly beneficial 
in maximizing the impact of both types of intervention.  A range of types of 
potential synergy are identified;   ESIF as a potential alternative source of funding for positively evaluated 
Framework Programme proposals that are currently not supported due to 
insufficient budget;  A source of funding for actions designed to build research and innovation 
capacity of actors;   Funding for “downstream” actions of Framework Programme research and 
innovation projects such as market up-take;  Combining funding for coordinated parallel actions that complement one 
another in specific place-based settings;  Fully integrated research and innovation projects that are jointly funded 
by ESIF and Framework Programme.  
This range of possibilities suggests coordination between Structural Funds and 
Research and Innovation at the strategic level and in the design of whole 
programmes.  However, there could also be actions to facilitate alignment 
between ESIF and Framework Programme at the level of individual calls for 
specific projects.   
Interviews conducted with a range of stakeholders, including ESIF Managing 
Authorities and H2020 NCPs revealed that there are some successful experiences 
already with regard to coordinating ESIF and H2020 funded projects.  These 
include examples where the results of H2020 projects are integrated into regional 
development initiatives funded by ESIF.  Also, examples were identified where 
ESIF investments in regional research infrastructures provided a platform for 
successful proposals for H2020 projects.  However, interviewees also drew 
attention to the need for awareness raising on the opportunities for synergies and 
harmonization of governance and management rules for the ESIF and Framework 
Programme.   
This discussion does have a bearing on the selection of indicators for future 
Widening.  While selection of indicators should not necessarily prevent closer 
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alignment between these policy arenas, it is possible that alignment could be 
much more likely to take place if some of the selected indicators are relevant to 
both.  Also, ESIF interventions are applied at the regional or sub-national scale 
while the Framework Programme largely seeks to influence national systems.  It 
is possible, therefore, that there could be advantages in selected some indicators 
that are relevant to both economic and research and innovation 
performance and also available at national as well as regional scales.   
At present, there is no explicit alignment of H2020 and ESIF in relation to 
targeting and use of indicators.  Structural Funds are focused at regional scale 
while as noted above, H2020 seeks to address EU-wide objectives through inputs 
of resource at the spatial level of Member States.  Also, target countries for 
Structural funding focuses on indicators of regional economic performance or 
status while H2020 emphasises measures of R&I performance.   These issues 
affecting alignment are considered in further in sections 9 and 10.   
7 Spreading Excellence and Widening Participation 
As noted in section 1, while the priorities of Horizon 2020 have focused on the 
performance of research and innovation in the EU as a whole, territorial issues 
have been addressed through the implementation of the “Spreading Excellence & 
Widening Participation” objective.  Actions under this objective have been 
designed to address uneven performance between Member States in research 
and innovation.  Actions have addressed the need to build capacity for research 
and foster networks between countries that are lagging behind and researchers in 
high performing Member States.  The “Widening agenda” also extends to 
spreading excellence to neighbouring non-Member States or “Associate 
Countries” that have subscribed to the concept of ERA.   
Table 5:  The Current “Widening Countries” under H2020 
Member States Associate Countries 
Bulgaria Albania 
Croatia Armenia 
Cyprus Bosnia and Herzegovina 
Czech Republic Faroe Islands 
Estonia Former Yugoslav Republic of Macedonia 
Hungary Georgia 
Latvia Moldova 
Lithuania Montenegro 
Luxembourg Serbia 
Malta Tunisia 
Poland Turkey 
Portugal Ukraine 
Romania  
Slovakia  
Slovenia  
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The Widening countries under H2020 were identified using a composite indicator 
of scientific and technological research excellence that combines four variables as 
follows (See Table 6 based on Hardeman et al 2013):   Number of highly cited publications of a country measured by the top 10% 
most cited publications per total number of publications;    Number of high quality patent applications of a country as measured by the 
number of patents filed under the Patent Cooperation Treaty (PCT) per million 
inhabitants;  Number of world class universities and research institutes in a country 
measured by the number of organisations of a country in the top 250 
universities and 50 research institutes divided by gross expenditure in R&D of 
a country; and  Number of high prestige research grants received by a country as measured 
by the total value of ERC grants received divided by public R&D expenditures 
of a country.   
The rankings produced by the Composite Research Excellence Index using the 
most recent data available in 2013 are shown in Table 6.  It is worth noting that 
the indicators used to create this index are all at national level, not regional or 
sub-national.  Also, the four indicators used capture different aspects of research 
and innovation - the first two can be regarded as “outputs” from the innovation 
system (publications quality and patents) while variables three and four represent 
different inputs to the process (Institutional capacity and funding).  These 
indicators are combined using a geometric average.  As a measure of central 
tendency, the geometric average reduces the effects of extreme values.  The 
target “Widening” countries were defined as those that fall below the threshold of 
70% of the EU average on this composite indicator (i.e. circa 33.5).    
SEWP’s key actions to address widening participation have included principally:   Teaming – creation of new or updating existing centres of excellence in low 
R&I performing Member States through “teaming” with internationally leading 
institutes in Europe  Twinning – strengthening a defined field of research inan emerging institution 
in a low performing R&I Member State by linking to at least two 
internationally leading counterparts in Europe  ERA Chairs – supports universities or research organisations in low R&I 
performing Member States by attracting and maintaining high quality human 
resources under the direction of an outstanding researcher or research 
manager (the “ERA-Chair holder”).   
In addition, SEWP provides funding to support Member States in the development 
and implementation of research and innovation policies (Policy-Support Facility; 
PSF) and support for a dedicated network of Widening National Contact Points 
(NCPs).  Support for Co-operation in Science and Technology (COST) is also 
provided for a range of other networking actions.   
The activities funded through SEWP have been subject to appraisal as part of the 
Horizon 2020 mid-term review and various other groups have reported on 
particular elements of the overall programme.  An issue paper prepared for the 
High level Group on maximizing the impact of EU Research and Innovation 
Programmes (EC 2017d) noted the high level of response to calls under SEWP, 
especially for Teaming Actions.   
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Table 6: Composite Research Excellence Index “2010” by Country 
EU Member State Research Excellence Index 
Switzerland* 97.6 
Netherlands 78.9 
Denmark 77.7 
Sweden 77.2 
Finland 62.9 
Germany 62.8 
Belgium 59.9 
United Kingdom 56.1 
Norway* 51.8 
Austria 50.5 
France 48.2 
EU (27 countries) 47.9 
Italy 43.1 
Iceland* 38.8 
Ireland 38.1 
Spain 36.6 
Greece 35.3 
Hungary 31.9 
Czech Republic 29.9 
Cyprus 27.8 
Slovenia 27.5 
Portugal 26.5 
Estonia 25.9 
Bulgaria 24.7 
Poland 20.5 
Luxembourg 19.8 
Romania 17.8 
Slovakia 17.7 
Malta 17.5 
Lithuania 13.9 
Croatia* 12.2 
Latvia 11.5 
 
Source: Abstracted from Hardeman S, Van Roy, V and Vertesy D (2013).  p. 55 
Includes data on several non-EU Countries at time of calculation, marked * 
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The interim evaluation of the Twinning and ERA Chairs actions (EC 2017) 
concluded that progress has been made in both these areas. Under Twinning, 
projects have successfully established effective partnerships between institutions. 
For instance, even by the time of the survey conducted Aug-Nov 2016, 43 
percent of the respondents to the Twinning survey (circa 45 replies) indicate that 
the project had led to the production of joint peer reviewed publications and one 
quarter had submitted a joint research proposal (EC 2017e p. 18).   
While SEWP has undoubtedly produced benefits for participants, assessing the 
overall impact of Widening is a more complex task. The final report on the 
Horizon 2020 Advisory Group (2016) on SEWP indicated that there had been 
early success by concentration of funding on leading locations and institutions 
within the target countries but that this may have contributed to an “emerging 
gap among the target countries” (H2020 Advisory Group, 2016, p. 2).  This 
suggests that there are still significant challenges for the Widening agenda.   
8 Implications for Indicators for Future Widening Action  
The themes discussed above could all have some bearing on the design of future 
Widening actions but also the choice of indicators and methodologies for targeting 
these Actions.  The following key points appear to be of relevance:   
a) Horizon 2020 is “designed to drive economic growth and create jobs by 
coupling R&I with excellent science….” 
b) Open innovation and open science is regarded as a key strategy for sustaining 
economic growth and the creation of high quality jobs.   
c) The concept of ERA is primarily a response to the identified need to 
strengthen and integrate the science base in the EU as a whole 
d) One key objective of ERA aims to increase collaboration between more 
effective national research systems  
e) There are still significant divides between member states in terms of 
performance in research and innovation.  These divides are not simply east –
west.  There are also significant and growing divides between EU-13 Member 
States and between north and south within the EU-15.   
f) Patterns of participation in H2020 are complex and not subject to simple 
explanation using single variables.  EU-13 Member States are more commonly 
found in the lower half of any ranking on different indicators (especially those 
that refer to coordinators).  However, there are significant exceptions to this 
generalisation.   
g) There are significant variations in patterns of R&I performance and also levels 
of H2020 participation at the regional scale.  R&I distribution in characterised 
by significant concentrations of activity in relatively few capital city-regions.   
h) Some large countries can display only moderate performance in R&I due to 
scale effects (averaging across regions with varied performance) 
i) Some very small countries can appear as outliers in distributions (both high 
and low) due to boundary effects and the influence of scale on data   
j) Indicators used to target Widening Countries under H2020 do not currently 
include measures of economic performance and indicators that are available 
at regional as well as national scale.  
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k) Published evaluations of H2020 and specific elements of the current SEWP 
programme conclude that there has been successful delivery.  In particular, 
there has been a high level of application especially for Teaming Actions.   
l) Evidence suggests that there is an emerging gap among the present target 
countries.  Also, there is a need to consider how to ensure positive legacy 
from the current SEWP programme.  
These preliminary conclusions from the review of literature suggest a number of 
general principles to guide selection of indicators that are relevant to future 
widening actions.    The discussion suggests that there is a need to consider socio-economic 
indicators alongside more immediate research & innovation measures in order 
to capture the overall intended purpose of investment in science and 
innovation.    The literature also indicates that the processes and institutions that generate 
research and innovation are complex and varied and that the performance of 
these national systems cannot easily be captured reliably in a single indicator.    Choice of indicators, however, not only needs to be justified in terms of 
relevance but also in terms of ease of data collection and analysis.  This is 
important not only for the efficiency with which data can be replicated in 
future but also in relation to communication of indicators to stakeholders.    Finally, the possibility of alignment between future Widening interventions 
and ESIF could be facilitated by selecting some indicators that are relevant to 
both economic and research and innovation performance and also available 
at national as well as regional scales.   
It is proposed therefore that a range of indicators should be considered covering 
both economic and research domains and including both single and composite 
forms of measurement. With this in mind, the following indicators have been 
selected as a possible basis for possible targeting of future Widening Actions:  
Socio-economic indicators  Socio-economic status – GPD per capita (PPS Index)  Productivity – GDP per worker / GDP per hour  Economic Structure – Percent of employment in knowledge intensive activity  Business Innovation - % Enterprises classed as “innovation active”  
Research and innovation single indicators  Expenditure - R&D intensity – Gross Research and Development Expenditure 
as a percent of GDP  Publication - Total number of highly-cited scientific publications per million 
population (citation window 2014-2016)  Publication – Proportion of total scientific publications that is highly-cited 
(citation window 2014-2016)  Research Excellence and Institutional Capability – Top 500 Universities  Patents – total number of PCT patent applications per million population 
Research and innovation composite indicators  Research composite indicator - JRC Research Excellence Indicator  Innovation composite indicator – European Innovation Scoreboard Index 
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9 Indicators for Future Widening Actions  
This section considers each of the “long-list” of indicators identified in chapter 9.  
The rationale for their consideration is explained and the technicalities of data 
collection are evaluated.  These indicators are all derived from data that is 
collected routinely for other purposes and likely to be available on a time series 
bases.  
9.1 Socio-economic status – GDP per capita (PPS Index) 
As argued elsewhere in this report, the commitment of the Commission to 
support investment in research and innovation arises from a desire to see 
improved socio-economic conditions across the European Union.  It is expected 
that increasing investment in research and development will create new 
knowledge, increase knowledge intensity in the economy, improve 
competitiveness and enhance wealth creation. Extending this logic, it can be 
argued that Member States with lower living standards have a greater need for 
interventions to support research and innovation activities.   
Gross Domestic Product (GDP) can be regarded as a measure of national wealth 
and expressed per capita, it is commonly viewed as a proxy for living standards.  
GDP measures the value of final output of goods and services produced by an 
economy less the value of any goods and services used in their creation. It is not 
a complete measure of the economy as it excludes some aspects such as unpaid 
work and activities in the informal economy. Also, it does not account for 
negative externalities created, for instance, by environmental degradation. 
However, expressed as a ratio to population, GDP is used as a broad indicator of 
variation in material living standards across different countries.  
The indicator available on Eurostat for cross-country comparison is GDP per 
capita in Purchasing Power Standards (PPS).  Eurostat footnotes to this dataset 
indicate that PPS expresses GDP in a common currency that seeks to minimize 
the effects of differences in price levels (i.e. the cost of living) between countries.  
The data is also available as an index with EU average set to 100 (Table 7).   
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Table 7:  EU Member States: GDP per capita 2016 
Index EU28=100 Current 
status 
GDP per capita (PPS 
index) 2016 
EU (28 countries)  100 
Luxembourg w 258 
Ireland  183 
Switzerland  161 
Norway  148 
Netherlands  128 
Austria  128 
Iceland  128 
Denmark  124 
Germany  123 
Sweden  123 
Belgium  118 
Finland  109 
United Kingdom  107 
France  104 
Italy  97 
Malta w 96 
Spain  92 
Czech Republic w 88 
Cyprus w 83 
Slovenia w 83 
Portugal w 77 
Slovakia w 77 
Estonia w 75 
Lithuania w 75 
Greece  68 
Poland w 68 
Hungary w 67 
Latvia w 65 
Croatia w 60 
Romania w 58 
Bulgaria w 49 
 
Source: Eurostat (last updated 14.02.2018) 
http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&plugin=1&language=en&pcode=tec001
14 
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9.2 Productivity – GDP per worker and per hour 
EU support for research and innovation is intended to improve the 
competitiveness of the economy through the impact that research outcomes have 
on the level of knowledge-intensity in the economy. The effect of this is to 
produce higher paid jobs and ultimately, to stimulate an increase in the level of 
labour productivity. It can be argued, therefore, that Member States that display 
lower levels of labour productivity have a greater need for interventions to 
stimulate research and innovation.   
The conventional measures of labour productivity are based on GDP per person 
employed or GDP per hour, both of which are available for country comparisons 
on a consistent basis on Eurostat (based on “purchasing power standards”, see 
above).  The notes to this dataset draw attention to the fact that “persons 
employed” do not distinguish between full-time and part-time employment which 
varies considerably between Member States.  For this reason, it is suggested that 
GDP per hour is a more accurate means of comparing levels of productivity 
between countries (Table 8).   
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Table 8:  EU Member States: Productivity 2016 
 Current 
status 
GDP per 
worker 
GDP per 
hour 
Index EU 28 = 100  2016 2016 
Ireland  190 179 
Luxembourg w 163 176 
Norway  128 146 
Belgium  130 137 
Denmark  112 130 
Germany  106 127 
Switzerland  124 127 
Netherlands  111 126 
France  115 125 
Austria  117 118 
Sweden  114 114 
Iceland  103 113 
Finland  109 109 
Italy  108 102 
United Kingdom  101 99 
Spain  102 98 
Slovenia w 81 79 
Slovakia w 82 77 
Cyprus w 84 77 
Malta w 93 75 
Czech Republic w 80 74 
Portugal w 78 68 
Greece  81 65 
Estonia w 72 63 
Croatia w 71 63 
Hungary w 68 63 
Lithuania w 72 63 
Poland w 74 59 
Romania w 62 56 
Latvia w 65 56 
Bulgaria w 45 45 
 
Source: Eurostat (last updated 14.02.2018) 
http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&plugin=1&language=en&pcode=tec001
14 
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9.3 Economic Structure – Employment in knowledge intensive activity 
Support for research and innovation is intended to increase competitiveness by 
its impact on the knowledge economy. In seeking to raise living standards and 
improve productivity, it might be expected, therefore, that the structure of the 
economy would shift away from labour-intensive activities towards those that are 
more knowledge-intensive.  Again, it can be argued that Member States whose 
economies have lower levels of knowledge intensity have a greater need for 
support to stimulate research and innovation.   
Data on the percentage of employment in knowledge intensive activities is 
available on Eurostat on an annual basis by Member State. “Activities” are 
defined using the 2 digit codes in the Statistical Classification of Economic 
Activities in the EU (NACE Revised version 2 introduced in 2008). An activity is 
classed as “knowledge intensive” if workers with higher level qualifications (levels 
5-8) represent more that 33% of total employment (Table 9).   
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Table 9:  EU Member States: Knowledge Intensity 2016 
 Current 
status 
% Empl Knowledge 
Intensive activity 
Luxembourg w 51.1 
Sweden  44.8 
United Kingdom  43.7 
Malta w 43.5 
Iceland  43.3 
Switzerland  42.9 
Belgium  42.5 
Ireland  41.1 
Norway  39.7 
France  39.4 
Denmark  38.8 
Netherlands  37.9 
Cyprus w 37.9 
Finland  37.5 
Germany  37.2 
Austria  36.2 
EU (28 countries)  36.1 
Greece  35.4 
Hungary w 34.9 
Slovenia w 34.7 
Estonia w 33.4 
Italy  32.9 
Spain  32.5 
Portugal w 32.4 
Lithuania w 32.2 
Latvia w 32.0 
Croatia w 31.7 
Czech Republic w 31.3 
Slovakia w 30.4 
Poland w 29.1 
Bulgaria w 28.2 
Romania w 21.1 
 
Source: Eurostat: Annual data on Employment in KIAs at National Level NACE Rev 2 (htec_kia_emp2) 
Last updated 17.01.18 
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9.4  Levels of Innovation in Business Enterprises 
Historically, it has proved problematic to assess the levels of innovation in 
business partly due to the challenges posed by defining “innovation” but also the 
cost of data collection. Since 2014, however, Member States have been required 
to conduct surveys of enterprises to contribute towards a European-wide 
“Community Innovation Survey” (CIS).  The survey is carried out every 2 years 
using a standardised survey instrument designed to record different types of 
innovation.  Each survey has a reference period.  Most recently published data is 
for 2014 with a focus on changes introduced in enterprises during 2012-14.  
Enterprise owners and managers are asked to indicate whether they have 
engaged in innovation activities in this time period and to describe the nature of 
that innovation (e.g. involved in new product, process, marketing initiative or 
R&D collaboration).   
Table 10 shows that the proportion of enterprises that are classed as “innovation-
active” during 2012-14 varied considerably between Member States.  Some 
Countries lie well above the EU average of 49.1%, in particular in Germany, 
Luxembourg, Belgium, Ireland and the UK which all score above 60%.  At the 
other extreme, innovation is much less widespread in enterprises in Estonia, 
Bulgaria, Hungary, Latvia, Poland and Romania (below 30%).  As might be 
expected, the existing Widening Countries are predominantly placed in the lower 
half of this distribution, although there are outliers where scores are higher for 
Portugal (54%) and more especially, Luxembourg (65.1%).   
This data can be further disaggregated to show how the characteristics of 
innovative processes vary between Member States.  Table 11, for instance, shows 
the proportion of designated innovative enterprises that are involved specifically 
in some form of research and development cooperation either with a Institute for 
Higher Education, research entity or public sector body.  This data indicates that, 
while innovation is not so widespread in most current Widening Countries, for 
some of these, the innovation that does occur involves longer-term commitments 
to collaboration.  The proportion of innovative small and medium-sized 
enterprises that are involved in R&D collaborations is well above average, for 
instance, in Estonia, Slovakia, Lithuania, Slovenia and Hungary.   
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Table 10: Innovative Enterprises as % of Total Number of Enterprises 
2014 
 Current 
Status 
% enterprises classed as 
“innovation-active”  
EU  49.1 
     
Germany  67.0 
Luxembourg w 65.1 
Belgium  64.2 
Ireland  61.0 
United Kingdom  60.2 
Austria  59.5 
France  56.4 
Netherlands  55.3 
Finland  55.3 
Sweden  54.2 
Portugal w 54.0 
Greece  51.0 
Denmark  49.5 
Italy  48.7 
Slovenia w 45.9 
Lithuania w 43.3 
Czech Republic w 42.0 
Cyprus w 41.8 
Malta w 41.2 
Croatia w 39.7 
Spain  36.4 
Slovakia w 31.8 
Estonia w 26.5 
Bulgaria w 26.1 
Hungary w 25.6 
Latvia w 25.5 
Poland w 21.0 
Romania w 12.8 
 
Data reported in “Science, Research and Innovation Performance of the EU 2018” and provided by 
Unit 4: Monitoring and Analysis of national research and innovation policies European Commission 
Data: Eurostat (Community Innovation Survey (CIS) 2014) 
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Table 11: % Share of Innovative Enterprises involved in R&D 
Cooperation 2014 
  Current Status 2014: Large 
companies 
2014: SMEs 
EU 28  55.4 31.5 
    
United Kingdom  68.0 61.0 
Belgium  75.6 55.2 
Estonia w 89.5 54.4 
Austria  75.5 48.2 
Slovakia w 74.1 44.9 
Lithuania w 66.7 43.0 
Slovenia w 66.7 42.2 
Greece  77.5 38.8 
Netherlands  52.1 37.7 
Hungary w 58.7 36.2 
Denmark  67.1 35.9 
Cyprus  88.5 35.6 
Finland  75.5 35.6 
France  62.8 33.5 
Sweden  61.8 31.2 
Spain  57.3 30.0 
Czech Republic w 59.6 29.8 
Romania w 37.9 29.7 
Ireland  55.4 29.4 
Croatia w 57.5 26.3 
Poland w 50.9 24.6 
Luxembourg w 42.6 22.5 
Latvia w 43.1 21.9 
Germany  46.4 19.8 
Bulgaria w 32.3 19.4 
Italy  42.4 18.5 
Portugal w 56.2 17.6 
Malta w 28.6 14.3 
 
Data reported in “Science, Research and Innovation Performance of the EU 2018” and provided by 
Unit 4: Monitoring and Analysis of national research and innovation policies European Commission 
Data: Eurostat (Community Innovation Survey (CIS) 2014) 
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9.5 R&D Expenditure  
The level of research and innovation activity can be measured using a variety of 
indicators that represent key inputs, activities as well as outputs.  The most 
significant input concerns funding or expenditure on research and development.  
At EU level, a key target for research and innovation relates to a commitment to 
increase expenditure on R&D to 3 percent by 2010 (Lisbon Target). Achieving this 
target has proved to be elusive1 but it remains a key goal for 2020.  R&D 
expenditure can be regarded as a significant and relevant measure of the level of 
research activity (Table 12).   
Reliance on R&D expenditure alone as an indicator of the need for future EU 
investment is, however, likely to introduce anomalies.  Member States vary, for 
instance, in their capacity to absorb R&D expenditure; this can be related to the 
prevalence of research-intensive universities or the preponderance of research 
institutes.  More significantly though, use of this measure to determine targeting 
for widening initiatives risks penalizing Member States that choose to prioritise 
R&D in national policies while rewarding those that may be underinvesting in their 
research and innovation activities.   
  
                                                 
1 http://bruegel.org/wp-content/uploads/2016/10/Presentation-Georgios-Petropolous.pdf  
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Table 12: EU Member States: R&D Intensity 
  Current status R&D Intensity (based on Gross 
R&D Expenditure as % GDP) 
2015 
EU 28 =100   
Sweden  160 
Austria  152 
Germany  145 
Denmark  142 
Finland  135 
Belgium  123 
France  109 
Netherlands  100 
Slovenia w 99 
United Kingdom  83 
Czech Republic w 83 
Estonia w 63 
Italy  63 
Portugal w 62 
Luxembourg w 61 
Spain  59 
Hungary w 59 
Ireland  58 
Greece  49 
Poland w 49 
Croatia w 41 
Slovakia w 39 
Bulgaria w 38 
Lithuania w 36 
Malta w 30 
Cyprus w 25 
Romania w 24 
Latvia w 22 
 
Source: Data compiled by Unit 4: Monitoring and Analysis of national research and innovation policies 
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9.6 Publication  
The level of publication is a significant measure of research output. The term 
“bibliometrics” is now commonly used to refer to the application of quantitative 
measures to assess various attributes of scientific production and communication. 
It is used, in particular to inform assessments of research quality (Butler 2008; 
Frey and Rost 2010) and research impact (Penfield et al 2014) as well as a means 
to map the evolution of different scientific fields (Liu et al 2015).  Research 
assessment exercises developed in recent years in many countries include 
bibliometrics as part of the process of assessing research.   
A key metric for assessing research quality concerns the rate at which a 
publication is cited.  Studies have shown that there is a degree of correlation 
between peer review assessments of research quality and levels of citation.  
However, authors also caution against over-reliance on citation data to assess 
quality.  While not denying the value of citation, Frey and Rost (2010) identify a 
range of shortcomings in using citation to infer research quality:    Citation does not distinguish whether a scholar is being cited for positive or 
negative reasons;   Publication is known to be subject to “herding” tendencies as ideas go in and 
out of fashion;   Citation does not necessarily mean that a publication has been read;   Citation habits vary between disciplines and fields of study which can make 
comparisons unreliable;   Easily accessed publications can be more highly referenced.   
Most authors conclude that bibliometrics are useful but as a check on 
conventional peer review methods (Penfield et al 2014). Butler (2008) suggests 
that bibliometrics play a role in that they make peer evaluation transparent as 
assessors need to justify evaluations that differ from bibliometrics.  
It should be noted that most previous published articles on the use of citation to 
infer research quality have been conducted in the context of national research 
quality assessments designed to determine funding of universities. They have not 
been developed to enable international comparisons.  It is quite likely that 
citation behaviour will vary between countries and the rate of citation could well 
be influenced by the varied size of research communities.  High quality research 
can also be published in different languages that have varied readership.  
While recognizing these caveats, data that compares the level of citation for 
Member States can be accessed on the EU Research and Innovation Observatory 
– H2020 Policy Support Facility.  Member States can be compared using the level 
of citation of publications associated with authors affiliated to each country (with 
adjustment for co-authoring). Scores for each country show the number of 
publications in the 10% most cited publications in a specified time period.  It is 
possible to express this as a proportion of all publications in each country or as an 
index relative to size of population.   
Table 13 shows highly cited publication relative to size of population. Member 
States deviate from the average considerably with high rates of citation in 
Denmark, Netherlands, Sweden, UK, Finland and Belgium but low levels in many 
existing widening countries (notably Bulgaria, Romania and Latvia).  Two current 
Widening Countries perform well (Slovenia, Luxembourg) while several countries 
not currently part of Widening are ranked below average (in particular, Greece).  
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Table 13: Highly cited publication per million population (Citation 
window 2014-2016) 
  Current 
status 
Total number of highly cited scientific 
publications per million population  
EU   100 
Denmark   257 
Netherlands   219 
Sweden   197 
United Kingdom   176 
Finland   169 
Belgium   152 
Ireland   135 
Austria   120 
Slovenia w 113 
Luxembourg w 111 
Germany   108 
Spain   90 
France   86 
Portugal w 83 
Italy   83 
Estonia w 69 
Cyprus w 67 
Greece   61 
Czech Republic w 55 
Malta w 31 
Hungary w 27 
Poland w 27 
Slovakia w 24 
Croatia w 24 
Lithuania w 22 
Romania w 14 
Latvia w 8 
Bulgaria w 8 
 
Source: Data compiled by Unit 4: Monitoring and Analysis of national research and innovation policies 
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The patterns created by any indicators can be affected considerably by the choice 
of denominator.  Citation data in Table 13 standardises the level of highly-cited 
publication by expressing this number in relation to size of population in each 
Member State.  A different pattern emerges, however, when the same data is 
expressed as a percentage of total publications.  Arguably, this indicator is a 
more direct surrogate of the quality of the research outputs from each Member 
State.  This data is ranked in Table 14.  On this indicator, Luxembourg is the only 
current “Widening” Member State above the EU average.   
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Table 14:  Highly –cited publication as % total publication 
 Current 
Status 
Top 10% highly cited 
publications as % all 
publications 
Index 
EU28=100 
EU 28  11.1 100 
United Kingdom  14.8 133.3 
Netherlands  14.3 128.8 
Denmark  13.2 118.9 
Belgium  12.6 113.5 
Ireland  11.9 107.2 
Austria  11.5 103.6 
Sweden  11.5 103.6 
Germany  11.5 103.6 
Luxembourg w 11.4 102.7 
France  11.3 101.8 
Finland  10.7 96.4 
Italy  10.1 91.0 
Cyprus w 9.6 86.5 
Spain  9.5 85.6 
Malta w 9.4 84.7 
Portugal w 8.9 80.2 
Greece  8.7 78.4 
Slovenia w 8.3 74.8 
Estonia w 7.8 70.3 
Czech Republic w 6.7 60.4 
Hungary w 5.7 51.4 
Slovakia w 5.3 47.7 
Poland w 4.8 43.2 
Romania w 4.8 43.2 
Croatia w 4.1 36.9 
Latvia w 3.7 33.3 
Lithuania w 3.7 33.3 
Bulgaria w 3.6 32.4 
 
Data reported in EC (2018) “Science, Research and Innovation Performance of the EU 2018” and 
provided by Unit 4: Monitoring and Analysis of national research and innovation policies European 
Commission 
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9.7 Research Excellence and Institutional Status of HEIs 
Previous attempts to assess the level of research excellence have included 
consideration of the distribution of highly ranked Institutions of Higher Education 
measured by their research impact.  A measure of this type, for instance, is 
included in the Joint Research Centre’s Research Excellence Index (see below).   
There are various published league tables of HEIs globally that attempt to rank 
institutions using combinations of indicators of teaching and research 
performance.  The two most widely used indicators are drawn from The Times 
Education (THE) rankings and the Shanghai Ranking (Academic Ranking of World 
Universities (ARWU)). These league tables are increasingly influential in shaping 
the strategic decisions of many HEIs that aspire to global status.  It should be 
noted, however, that while there are broad similarities between these various 
rankings, the outcome for individual institutions can vary considerably depending 
on which indicators are included or excluded.  For instance, the ARWU ranking is 
based on six indicators that capture different types of institutional scientific 
output while THE covers a wider range of attributes including more qualitative 
assessments of reputation and image.  These measures are perhaps subjective 
but they are nonetheless significant in determining the global reach and influence 
exercised by institutions.   
It should be noted that the use of this indicator is not robust for small countries 
that have a low number of institutions.  It is also the case that high performing 
HEIs are concentrated in relatively few countries and there are several Member 
States that do not have any HEIs listed in these tables (EC 2018, p. 167).   
These points can be illustrated with reference to data from the Times Higher 
Education that lists the top 500 universities worldwide according to a range of 
measures that include consideration of the following aspects of performance:   Teaching (aspects of the learning environment)  Research indicators (volume, income, reputation)  Citations (research influence)  International outlook (staff, students and research)  Industry income (knowledge transfer) 
This listing for 2018 is shown in Table 15.  The most striking feature of this listing 
is that that the majority of the current Widening countries (12 Member States) do 
not have any institutions ranked in the top 500.  Luxembourg is the most highly 
ranked country, although this needs careful interpretation due to the Index being 
expressed as a number related to resident population. As noted elsewhere in this 
report, per capita indicators for Luxembourg can be misleading due to high levels 
of in-commuting which reduce the size of the denominator.  Estonia, however, 
also performs well above average on this indicator.  These characteristics suggest 
that league tables of this type may not be reliable as a single indicator of 
research and innovation performance but they may have some value as part of a 
combined index or a methodology that uses a number of indicators. 
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Table 15:  Number of top 500 universities in the Times Higher Education 
World University Ranking per million population(1), 2018 
  Current 
Status 
Number of to 500 Universities 
per Million Popn 2018(1) 
EU(2)  0.44 
Luxembourg w 1.74 
Ireland  1.48 
Finland  1.28 
Denmark  1.23 
Sweden  1.12 
United Kingdom  0.90 
Austria  0.81 
Netherlands  0.77 
Estonia w 0.76 
Belgium  0.71 
Germany  0.52 
Italy  0.51 
France  0.30 
Spain  0.15 
Hungary w 0.10 
Greece  0.09 
Not listed:   
Bulgaria w  
Croatia w  
Cyprus w  
Czech Republic w  
Latvia w  
Lithuania w  
Malta w  
Poland w  
Portugal w  
Romania w  
Slovakia w  
Slovenia w  
 
Source: Data reported in EC (2018) “Science, Research and Innovation Performance of the EU 2018” 
and provided by Unit 4: Monitoring and Analysis of national research and innovation policies European 
Commission 
1) Times Higher Education - World university rankings (https://www.timeshighereducation.com/world-
university-rankings/2018) 
2) EU was estimated by DG Research and Innovation based on the data available for the Member 
States 
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9.8 Patenting 
Patent statistics are commonly used as a measure of innovative performance not 
only in business but also across territories.  Patent applications are counted in the 
year in which they were filed and can be assigned to countries according to the 
applicant’s place of residence.  As in the case of publications, fractional counting 
can be used where there are multiple applicants to avoid double counting.  Patent 
applications can be expressed in terms rates per million population as in 
indication of the level of inventiveness in each Member State (Table 16).   
Data on patenting attributed to the European Patent Office (EPO) is available on 
Eurostat by Member State.  The OECD also publishes patent data filed under the 
Patent Cooperation Treaty (PCT) that enables inventors to submit one application 
covering a very wide range of signatory countries including Member States of the 
EU.  
It is important to recognize that there are widely recognized disadvantages to 
using patent data to describe patterns of innovation (Archibugi and Pianta 1996).  
There is likely to be spatial bias in patent data particularly affecting smaller 
Member States and patterns at regional level. Patenting is costly and so the 
propensity to apply for patents is likely to vary between Member States. There 
are also likely to be variations in rates of patenting between counties caused by 
structural differences, as patenting is more common in some sectors than others.  
Finally, the location at which larger firms in particular choose to apply for patents 
may not necessarily correspond with the locations where such activities take 
place, as when files are submitted from a head office location.  A study by 
Svensson (2015) in Sweden also shows that “patent quality” varies as not all 
patents lead to commercialization.   
Despite these shortcomings, patent data has been used as a surrogate measure 
of innovation in research for several decades and this data is still regarded as the 
most reliable measure of spatial variation in innovation that is currently available 
(Sleiwaegen and Borardi 2014).  
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Table 16: EU Member States: PCT Patent Applications 2014 
  Current 
status 
Total number of PCT Patent 
applications per million popn 
   2014 
EU  100 
Sweden  319 
Finland  246 
Germany  216 
Netherlands  209 
Denmark  207 
Austria  173 
Luxembourg w 139 
France  120 
Belgium  107 
United Kingdom  96 
Ireland  90 
Slovenia w 67 
Italy  56 
Spain  39 
Malta w 32 
Estonia w 27 
Czech Republic w 24 
Hungary w 24 
Cyprus w 17 
Lithuania w 16 
Portugal w 15 
Greece  11 
Poland w 11 
Croatia w 10 
Slovakia w 9 
Bulgaria w 8 
Latvia w 5 
Romania w 4 
 
Source: Data compiled by Unit 4: Monitoring and Analysis of national research and innovation policies 
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9.9 JRC Research Excellence Index 
As noted earlier in this report, the H2020 definition of Widening Countries was 
based on a composite indicator developed by the Joint Research Centre (JRC).  
The methodology used in this process has been outlined in Hardeman et al 
(2013) and updated in Hardeman and Vertesy (2015). Briefly, the method 
devised then combined the following four variables into one composite indicator:   Highly cited publications per total publications - a count of the 10 percent 
most highly cited publications divided by the total publications with an author 
from each country;   PCT Patent applications per million inhabitants – Patent applications filed 
under PCT by inventors’ country of residence (fractional counting) per million 
inhabitants;   Top universities and public research institutes – Number of the top 250 world 
scientific universities and top 50 public research organisations in a country 
divided by total R&D expenditures;   Value of ERC grants received by country of host organization divided by public 
R&D expenditures.  
It should be noted that three of these four variables are similar to indicators 
already discussed – citations, patents and high ranking universities– although 
“total publications” rather than “total population” is used as a denominator for 
publications. It is likely that this will create considerable variability in this data for 
countries with small scientific communities and low levels of publication. The third 
variable (top universities and public research institutes) is also likely to be 
associated with very low counts in some smaller countries that could generate 
anomalies.   
Correlation of these four variables demonstrated very strong association between 
them (all significant at the 1% level). This close association was confirmed using 
principle components analysis that revealed that the first component accounted 
for over 70 percent of all variability in the dataset.   
Despite being highly correlated, the four variables displayed very different 
degrees of variance and it was noted that the outliers in some distributions could 
have a significant effect on use of the mean (arithmetic average) to create the 
composite index.  To reduce this, the four variables were combined using a 
geometric average.  
In February 2018, JRC calculated at update of the Research Excellence Index 
using the most recent data available, following, to the extent possible, the 
methodology described in Hardeman et al (2013) and Hardeman and Vertesy 
(2015).  It should be noted, however, that while this index has been produced in 
2018, the input data is drawn mainly from performance in 2015 (Table 17).   
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Table 17:  EU Member States: JRC Research Excellence Index 2015 
  Current 
status 
JRC Research 
Excellence 
Index (REI) 
2015 
REI 2015 
Indexed to 
EU28=100 
EU 28  41.3 100.0 
Netherlands  59.5 144.1 
United Kingdom  56.2 136.1 
Finland  52.7 127.6 
Ireland  52.5 127.1 
Sweden  52.0 125.9 
Denmark  52.0 125.9 
Austria  46.8 113.3 
Belgium  45.3 109.7 
Germany  43.2 104.6 
France  40.5 98.1 
Italy  37.9 91.8 
Spain  34.7 84.0 
Estonia w 33.2 80.4 
Portugal w 32.3 78.2 
Greece  30.8 74.6 
Hungary w 30.5 73.8 
Cyprus w 29.1 70.5 
Luxembourg w 26.1 63.2 
Czech Republic w 21.4 51.8 
Slovenia w 19.0 46.0 
Malta w 17.6 42.6 
Poland w 16.4 39.7 
Croatia w 16.2 39.2 
Latvia w 14.9 36.1 
Slovakia w 14.4 34.9 
Romania w 13.9 33.7 
Bulgaria w 13.6 32.9 
Lithuania w 13.5 32.7 
 
Source: Data provided by Joint Research Centre; The Research Excellence Index February 2018 
Revision.   
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9.10 European Innovation Scoreboard Index 
The European Innovation Scoreboard (EIS) is an index that combines a wide 
range of measures of innovation designed to capture progress towards achieving 
the goals of the Europe 2020 Strategy.  Initially the indicator was based on four 
components.  As in the case of the JRC Research Excellence index, several of the 
single indicators evaluated above are incorporated into the EIS, some using 
different denominators.  These are:   PCT patent applications per billion GDP;   Share of employees in knowledge-intensive industries in total business 
enterprise sector employment and the share of medium-high and high-tech 
goods in total exports;   Share of knowledge-intensive services in total service exports;  Employment in fast-growing firms from innovative sectors.   
Since 2014, however, the European Innovation Scoreboard (EIS) Index has been 
revised and extended and the latest version introduced in 2017 distinguishes 
between ten innovation dimensions and incorporates 27 different variables.  The 
ten dimensions are as follows:   Human resources  Attractive research systems  Innovation-friendly environment  Finance and support  Firm investments  Innovators  Iinkages  Intellectual property  Sales impact 
The EIS Index has been subject to critique.  The index combines measures of 
research input, activity and output which makes it difficult to interpret trends 
over time. It has been suggested that the indicator depends too much on formal 
R&D and associated radical innovations and does not capture the significance of 
smaller scale incremental innovation that characterizes change in small and 
medium-sized enterprises.  Janger et al (2016) also argue that the EIS Index is 
not consistent with current policy thinking in relation to smart specialization 
because several of the variables focus on a defined set of “knowledge-intensive 
industries” which overlook the importance of improvements in knowledge 
intensity within traditional sectors of economies.  
Despite these criticisms, the EIS Index combines a large set of variables and is 
therefore less exposed to anomalies that can be found in single indicators. It is 
also a widely used and accepted indicator in policymaking at both national and 
regional scales and offers a broad perspective on innovative performance (Table 
18).  
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Table 18:  EU Member States: Summary Innovation Index 
  Current 
status 
European Innovation Scoreboard 
Summary Innovation Index 
    2016 
EU   100 
Sweden   141 
Denmark   134 
Finland   128 
Netherlands   127 
United Kingdom   123 
Germany   121 
Austria   119 
Belgium   119 
Luxembourg w 119 
Ireland   114 
France   107 
Slovenia w 96 
Czech Republic w 83 
Portugal w 81 
Estonia w 78 
Lithuania w 78 
Spain   77 
Malta w 75 
Italy   74 
Cyprus w 73 
Slovakia w 69 
Greece   67 
Hungary w 66 
Latvia w 57 
Poland w 54 
Croatia w 54 
Bulgaria w 47 
Romania w 33 
 
Source: Data compiled by Unit 4: Monitoring and Analysis of national research and innovation policies 
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10 Conclusion and Recommendations 
The indicators presented in section 10 are assessed in summary in Table 19. As 
shown, the various indicators vary in character across a range of criteria, 
including relevance to the issues of Widening, timeliness, spatial scales, 
complexity and coverage within and beyond EU States.  Given the complexities of 
the research and innovation process, none of these indicators can be regarded as 
a “perfect” solution to the measurement problem. However, identifying the main 
advantages and disadvantages of each indicator ensures an informed approach to 
selecting indicators that best reflect the purpose of Widening.   
The information presented in Table 19a, 19b and 19c suggests the following key 
points:  
10.1 Economic Indicators 
GDP per head as a measure of level of economic development has significant 
advantages in terms of timeliness, spatial scale and coverage.  GDP per worker 
or per hour has similar advantages but involves more complexities in terms of 
concept (productivity) and measurement (hours worked).   
The proportion of people employed in knowledge-intensive activity has 
many advantages in terms of timeliness, spatial scale, coverage and is relatively 
simple to calculate from published statistics. The major disadvantage is that this 
overlooks the possible impact of innovation within traditional sectors.    
Data on levels of business innovation and engagement in R&D 
collaborations from the Community Innovation Survey adds very useful insights 
and patterns, but has disadvantages in terms of timeliness, coverage and 
reliability especially for smaller territories.   
10.2 Research & Innovation single indicators 
Selecting a single indicator to represent research & innovation performance is 
more difficult due to the very varied nature of outputs and outcomes.  R&D 
Expenditure (Intensity) is the most commonly used measure but this has 
significant shortcomings for the purpose of targeting for future widening as 
Countries that strive to meet targets can be penalized for this effort.   
The distribution of the top 500 HEIs is clearly relevant and simple to apply 
but rankings are based on complex combinations of factors and can be disputed.   
Despite their limitations, the level of citation for publications and numbers of 
patents most closely reflect readily-available outputs from the research and 
innovation processes (at least for physical products).  This data is collected 
systematically and displays good coverage.   
10.3 Research & Innovation composite indicators 
As a general principle, indicators that combine different single measures can 
better reflect the range of outputs and outcomes from research and 
innovation processes.  There is less likelihood of generating anomalies due to 
averaging effects of combining different datasets.   
There are disadvantages in reliance on composite indicators because of their 
complexity, lack of timeliness and varied availability for countries outside 
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the EU.  Patterns displayed by composite indicators are also difficult to 
interpret.   
Of the two composite indicators examined, there is some overlap between them 
in terms of source data (most recent versions both include, for instance, patent 
data and citation data).   
The European Innovation Scoreboard Index is much better established and 
accepted in practice and covers a wider range of outcomes for innovation as well 
as research.  It has also been subject to greater scrutiny and testing for 
sensitivity to data changes.   
The JRC Research Excellence Index is more focused on research outcomes but 
is less widely applied in policymaking.  Due to changes in source data, it has also 
not been possible to replicate precisely the method used in 2013 using more 
recent data.   
10.4 Summary  
Based on the assessment of the options, it is suggested that the most appropriate 
and transparent method for identifying future target countries for widening 
interventions could involve filtering countries on three selected single variables 
representing economic status, research and innovation.  From the assessments 
made, it is suggested that the three most suited would be:   Economic status – GDP per head  Research performance - % of scientific publications in the top 10% citations  Innovation performance – Number of PCT Patent applications per million 
population.   
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Table 19a: Indicators for future Widening Actions: Economic Indicators Summary Assessment 
Indicator Source Timeliness and 
availability 
Spatial scale Complexity of 
indicator 
Coverage Reliability and other issues 
GDP per 
head 
Eurostat Annual  National and 
regional 
Well established 
methodology 
Widespread use 
in EU and 
globally 
GDP is based on “production” and 
may not always reflect individual or 
household standard of living. 
GDP per head can be affected by 
variations in population age structure   
GDP per hour Eurostat Annual  National and 
regional 
Well-established 
methodology 
Widespread use 
in EU and 
globally 
GDP per hour can be distorted by 
variations in working patterns and 
employment in different countries.  
“Productivity” is a complex concept   
% empl in 
knowledge 
intensive 
activity 
Eurostat Annual National and 
regional 
Relatively simple 
measure based on 
employment 
structure 
Based on data 
that is widely 
available 
Based on an fixed definition of 
“knowledge industries” 
Growth in traditional sectors due to 
innovation will be regarded as 
negative 
% 
Enterprises 
that are 
innovation 
active 
Eurostat - data 
derived from 
Community 
Innovation 
Survey 
Biennial 
Time delay in 
publication 
National 
Regional data 
available but 
low sample 
sizes 
Based on a series 
of questions in a 
standard 
questionnaire  
Covers all EU 
countries and 
some non-EU 
European 
Sample sizes can be low in smaller 
countries and in most regions.   
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Table 19b: Indicators for future Widening Actions: R&I Single Indicators Summary Assessment 
Indicator Source Timeliness and 
availability 
Spatial scale Complexity of 
indicator 
Coverage Reliability and other issues 
Gross R&D 
expenditure 
as % GDP 
Eurostat Annual 
 
National only Simple measure of 
expenditure on 
national accounts 
Widely available 
within and 
outside EU 
Single indicator that only 
measures financial inputs.  
Countries may be penalized for 
responding to EU targets 
Publication – 
high citation 
per m popn 
Web of Science 
database 
accessed via 
CWTS Leiden 
Ranking 
Annual 
2 year delay in 
publication 
National and 
regional 
Data is complex to 
analyse due to time 
lag in citation 
Citation data 
has wide 
international 
coverage 
Single indicator 
Citation data on its own can be 
misleading (see section 11.6) 
Publication - 
% highly 
cited 
publications  
Web of Science 
database 
accessed via 
CWTS Leiden 
Ranking 
Annual  
2 year delay in 
publication 
National and 
regional 
Data is complex to 
analyse due to time 
lag in citation 
Citation data 
has wide 
international 
coverage 
Citation data can be misleading - 
effects of “herding”, variations in 
size of academia, impacts of social 
media 
Research 
Excellence 
and Top 500 
HEIs  
Times Higher 
Education 
Published 
annually by 
Times Higher 
Education (THE) 
Institutional-level 
data that can be 
aggregated to 
any scale.   
Ranking is based on 
a complex 
combination of 
institutional factors 
Global coverage Coverage of the top 500 HEIs is 
sparse for many countries where 
there is no representation  
Total n of 
PCT patent 
applications 
for m popn 
Eurostat Annual National Regional 
data available 
but less reliable 
Some complexity at 
small scales in 
attributing patents 
to locations 
Global coverage Single indicator 
Patenting data on its own can be 
misleading (see section 10.8) 
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Table 19c: Indicators for future Widening Actions: R&I Composite Indicators Summary Assessment 
Indicator Source Timeliness and 
availability 
Spatial scale Complexity of 
indicator 
Coverage Reliability and other issues 
JRC 
Research 
Excellence 
Index 
Joint Research 
Centre 
Provisional data 
has recently been 
calculated to 
create an annual 
time series   
National only Time consuming to 
replicate dataset 
Covers EU 
countries with 
some 
international 
comparators 
Method combines data that has been 
critiqued above  
Outcome depends on implicit 
assumptions  
European 
Scoreboard 
Innovation 
Summary 
Innovation 
Index 
European 
Innovation 
Scoreboard 
(EC) 
Annual National and 
regional  
Current method is 
complex involving 
combination of 27 
different variables   
Coverage limited 
beyond EU 
Reliance on measures associated with 
formal R&D rather than incremental 
innovation 
Under-represents technical innovation 
in traditional sectors 
 
 49 
 
 
10.5 Using Indicators as Filters for Identifying Future Widening Countries 
Table 20 summarises the patterns in the data assembled in this report.  This shows 
which Member States fall below the EU average on each of the variables listed.  It can 
be seen that there are 17 Member States that fall below the average on the three key 
variables that represent economic status and the two most suitable and widely accepted 
indicators of research performance and innovation:  GDP Per head, % highly cited 
publications and Patenting.  Using these three variables as filters with the EU average 
as the threshold, the targets for future widening interventions would include all the 
existing Widening Countries with the exception of Luxembourg but would include also 
Italy, Spain and Greece.   
Table 20: Member States ranked below the EU28 average for each Indicators 
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Austria                         
Belgium                         
Bulgaria w X X X X X X X X X X X 
Croatia w X X X X X X X X X X X 
Cyprus w X X   X X X X X X X X 
Czech R w X X X X X X X X X X X 
Denmark                         
Estonia w X X X X X X X   X X X 
Finland               X         
France             X   X   X   
Germany                         
Greece   X X X   X X X X X X X 
Hungary w X X X X X X X X X X X 
Ireland           X       X     
Italy   X   X X X X X   X X X 
Latvia w X X X X X X X X X X X 
Lithuania w X X X X X X X X X X X 
Luxembourg w         X         X   
Malta w X X   X X X X X X X X 
Netherlands                         
Poland w X X X X X X X X X X X 
Portugal w X X X   X X X X X X X 
Romania w X X X X X X X X X X X 
Slovakia w X X X X X X X X X X X 
Slovenia w X X X X X   X X X X X 
Spain   X X X X X X X X X X X 
Sweden                         
UK     X     X       X     
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A similar analysis can be performed using the 90% of the EU average as the threshold 
(Table 21).  Using the same three key variables and applying the 90% threshold, the 
targets for future widening interventions would include all the existing Widening 
Countries with the exception of Luxembourg and Malta but add Greece as a target 
country.   
Table 21: Member States ranked below 90 percentile across each Indicators 
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Austria                         
Belgium                         
Bulgaria w X X X X X X X X X X X 
Croatia w X X X X X X X X X X X 
Cyprus w X X   X X X X X X X X 
Czech R w X X X X X X X X X X X 
Denmark                         
Estonia w X X   X X X X   X X X 
Finland                         
France             X   X       
Germany                         
Greece   X X     X X X X X X X 
Hungary w X X   X X X X X X X X 
Ireland           X             
Italy           X X     X   X 
Latvia w X X X X X X X X X X X 
Lithuania w X X X X X X X X X X X 
Luxembourg w         X         X   
Malta w   X   X X X X X X X X 
Netherlands                         
Poland w X X X X X X X X X X X 
Portugal w X X X   X X X X X X X 
Romania w X X X X X X X X X X X 
Slovakia w X X X X X X X X X X X 
Slovenia w X X         X X X X   
Spain         X X   X X X X X 
Sweden                         
UK           X             
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While it is recommended that the Commission explore further the use of these three 
variables together as a basis for identifying target Countries for Widening, it is 
recognized that policymakers may still prefer a single indicator solution.  In these 
circumstances, the relative reliability of the three shortlisted indicators must be 
considered, but so too the question would arise as to what type of outcome from 
Widening Actions the Commission wishes to emphasise – the quality of research outputs, 
commercialization of research through patenting or its subsequent impact on the 
economic performance of different Member States.  In addressing this question, it is 
evident that the quality of scientific publication is the most direct and least 
ambiguous outcome from any investment in research activity.  This argument could be 
used to justify selecting “% of scientific publications in the top 10% citations” as a key 
indicator.  The advantages of using this as a single indicator, however, would need to be 
weighed against the shortcoming of this particular data as illustrated in section 10.6 and 
summarized in tables 19a-c.   
Finally it is recommended that whether a combination of variables or single variable is 
used for identifying Widening Member States, there is a need to carry out further 
sensitivity checks on the selected data.  These indicators may vary in the level of 
volatility from year to year, so some time series analysis would be prudent.  Also, these 
variables may show different types of volatility in different countries, especially in smaller 
Member States.   
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Getting in touch with the EU 
 
IN PERSON 
All over the European Union there are hundreds of Europe Direct Information Centres.  
You can find the address of the centre nearest you at: http://europa.eu/contact 
 
ON THE PHONE OR BY E-MAIL 
Europe Direct is a service that answers your questions about the European Union.  
You can contact this service  
– by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls),  
– at the following standard number: +32 22999696 or  
– by electronic mail via: http://europa.eu/contact 
 
 
Finding information about the EU 
 
ONLINE 
Information about the European Union in all the official languages of the EU is available on the Europa website at:  
http://europa.eu 
 
EU PUBLICATIONS 
You can download or order free and priced EU publications from EU Bookshop at:  
http://bookshop.europa.eu. Multiple copies of free publications may be obtained  
by contacting Europe Direct or your local information centre (see http://europa.eu/contact) 
 
EU LAW AND RELATED DOCUMENTS 
For access to legal information from the EU, including all EU law since 1951 in all the official language versions,  
go to EUR-Lex at: http://eur-lex.europa.eu 
 
OPEN DATA FROM THE EU 
The EU Open Data Portal (http://data.europa.eu/euodp/en/data) provides access to  
datasets from the EU. Data can be downloaded and reused for free, both for commercial and  
non-commercial purposes. 
 
 
  
 
 
The purpose of this report is to assess the criteria that might be used to assist in 
targeting future “widening actions” that are intended to address inequality in research 
and innovation performance between EU Member States.  A range of single indicators is 
assessed including measures based on expenditure, publication and patenting. 
Composite indicators are also considered. The report further includes socio-economic 
indicators alongside conventional measures of research and innovation. It is 
recommended that the Commission consider further the merits of a “filtering” 
methodology based on headline measures of economic performance (GDP per head), 
research performance (scientific publication in the top 10% citations) and innovation 
(PCT patent applications).   
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